PE-backed Sterigenics appoints new CEO

By Iris Dorbian — 10 months ago

Sterigenics International LLC, which is backed by Warburg Pincus and GTCR, has named Michael B. Petras Jr. as CEO. The appointment becomes effective June 20, 2016. Petras will succeed Michael Mulhern, who has been tapped as executive chairman of the Sterigenics board of directors. Most recently, Petras served as president of Cardinal Health Inc‘s post-acute solutions businesses. Sterigenics is a provider of contract sterilization, gamma technologies and medical isotopes.